Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
13.95
-0.96 (-6.44%)
At close: May 9, 2025, 4:00 PM
14.25
+0.30 (2.15%)
After-hours: May 9, 2025, 7:49 PM EDT

Beta Bionics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
42.4530.4326.5727.68
Short-Term Investments
189.0273.1470.18-
Cash & Short-Term Investments
231.47103.5896.7527.68
Cash Growth
736.40%7.06%249.58%-
Receivables
9.06124.45-
Inventory
15.7313.321.25-
Prepaid Expenses
3.442.980.910.54
Other Current Assets
2.211.050.280.25
Total Current Assets
261.92132.92103.6228.47
Property, Plant & Equipment
11.8611.426.26.87
Long-Term Deferred Charges
-5.05--
Other Long-Term Assets
0.250.250.220.19
Total Assets
338.02149.65110.0435.53
Accounts Payable
3.452.851.170.43
Accrued Expenses
8.3113.337.076.14
Current Portion of Leases
1.521.531.220.98
Current Unearned Revenue
0.950.940.09-
Other Current Liabilities
2.262.51.051.32
Total Current Liabilities
16.4921.1510.618.87
Long-Term Leases
5.455.7333.16
Long-Term Unearned Revenue
2.331.860.26-
Other Long-Term Liabilities
-44.937.5710.5
Total Liabilities
24.2773.6351.4322.53
Common Stock
0000
Additional Paid-In Capital
638.951.3126.4215.53
Retained Earnings
-325.39-296.74-229.66-185.57
Comprehensive Income & Other
0.240.070.14-
Total Common Equity
313.75-245.36-203.11-170.03
Shareholders' Equity
313.7576.0158.6113
Total Liabilities & Equity
338.02149.65110.0435.53
Total Debt
6.977.264.224.13
Net Cash (Debt)
224.596.3292.5223.54
Net Cash Growth
853.61%4.11%293.01%-
Net Cash Per Share
17.9115.1317.444.71
Filing Date Shares Outstanding
43.3643.355.035
Total Common Shares Outstanding
43.356.675.035
Working Capital
245.42111.7893.0219.59
Book Value Per Share
7.24-36.80-40.39-34.02
Tangible Book Value
313.75-245.36-203.11-170.03
Tangible Book Value Per Share
7.24-36.80-40.39-34.02
Machinery
7.947.485.785.56
Construction In Progress
2.31.740.170.18
Leasehold Improvements
0.830.810.950.95
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q